LBA13 Dostarlimab + chemotherapy (CT) vs pembrolizumab + CT in metastatic non-squamous non-small cell lung cancer (NSCLC): Updated Asian subgroup analyses of the PERLA trial
| Autor: | Lee, D.H., Ahn, J.S., Lin, S-H., Ulanska, M., Lopez, G.A., Chian, C-F., Cho, L., Szijgyarto, Z., Stjepanovic, N., Lim, S.M. |
|---|---|
| Zdroj: | In Annals of Oncology November 2023 34 Supplement 4:S1662-S1663 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|